Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD | Market Cap | 34.26B |
| Revenue (ttm) | 184.58M |
| Net Income (ttm) | 98.29M |
| Shares Out | 104.46M |
| EPS (ttm) | 0.94 |
| PE Ratio | 348.58 |
| Forward PE | 250.23 |
| Dividend | 0.50 (0.15%) |
| Ex-Dividend Date | Feb 27, 2025 |
| Volume | 160,487 |
| Average Volume | 168,288 |
| Open | 325.25 |
| Previous Close | 330.48 |
| Day's Range | 325.10 - 332.42 |
| 52-Week Range | 121.21 - 336.00 |
| Beta | 0.44 |
| RSI | 77.98 |
| Earnings Date | Aug 14, 2025 |
About Pro Medicus
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and commu... [Read more]
Financial Performance
In 2024, Pro Medicus's revenue was 161.50 million, an increase of 29.30% compared to the previous year's 124.90 million. Earnings were 82.79 million, an increase of 36.52%.
Financial StatementsNews
The 10 wealthiest executives in the ASX 300 revealed
Healthcare and tech company bosses, including the co-founders of the ASX’s newest $30 billion company Pro Medicus, dominate the Rich Bosses list.
ASX to rise; Wall St rallies; bitcoin tops $US112k
Shares open higher; property stocks rebound; Pro Medicus continues charge; CSL remains “undervalued”: Morningstar. Follow live.
Pro Medicus runs to $300 so fast investors can’t catch up
Whenever the healthcare imaging software group signs a new customer contract, fund managers hide under their desks. This latest one really hurts.
ASX flat as miners gain, but banks fall; all eyes on GemLife IPO
Shares fall; Pro Medicus cracks record; Japanese giants buy into Gold Hydrogen; Rio Tinto firm to invest $1.7b into Quebec facilities. Follow live.
Can billionaire Anthony Hall build the next great seafood business?
The businessman made his fortune in medical imaging giant Pro Medicus. He’s snapping up abalone producers, oyster farms and fisheries for his next venture.
Pro Medicus targets $894M forward revenue with expanded cloud-based deals and AI focus
Pro Medicus reports record Q2 2025 results with 31.1% revenue growth, $894M projected forward revenue, and strong U.S. penetration.
Pro Medicus Limited (PMCUF) Q2 2025 Earnings Call Transcript
ASX 200 LIVE: COH hikes dividend, shares slump; Donald Trump tariff plans fails to deter traders as sharemarket rises.
Shares lift; CBA sells off after shares peak; Pro Medicus upgraded; Cochlear, AMP down on profit blow; Mirvac earnings fall to 0¢; $A nears two-month high.
Pro Medicus Ltd (PMCUF) (Q1 2025) Earnings Call Highlights: Record Revenue Growth and Strategic ...
Pro Medicus Ltd (PMCUF) (Q1 2025) Earnings Call Highlights: Record Revenue Growth and Strategic Expansions
Half Year 2025 Pro Medicus Ltd Earnings Call Transcript
Half Year 2025 Pro Medicus Ltd Earnings Call Transcript
Pro Medicus billionaires in $500m sell-down
The trade crossed the screen in two lines on Tuesday afternoon, with about 2 million shares changing hands at last price.
Rocket stock Pro Medicus redefines what’s possible
The medical software company is the sort of investment that makes you glad your job does not decide on picking whether it is a market winner or loser.
Earnings-season surprises shake up ASX short sellers
Fortescue, Woodside Energy and Pro Medicus have topped the list of companies being bet against as hedge funds rework their strategies after reporting season.
Why tech bolters are lighting up reporting season
WiseTech, Pro Medicus, Life 360 and REA Group have turned heads this season as tech proves the sweet spot for growth investors again.
Pro Medicus Limited (PMCUF) Q4 2024 Earnings Call Transcript
Pro Medicus GAAP EPS of A$0.79, revenue of A$166.33M
Pro Medicus share surge defies growth warning
Shares in market darling Pro Medicus jumped on the company’s latest bumper profit, but its CEO says that level of growth will be hard to maintain.
The five best-performing ASX 200 stocks this financial year
Healthcare software developer Pro Medicus narrowly bested family monitoring app Life360 to be the top-performing stock, with a 118.7 per cent return in 12 months.
The ASX business so good ‘you can’t put a sell on it’
Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.
Why Paradice is backing Seven Group’s bid for Boral
Mid cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.
ASX PME:
A $2.8 million share buyback helped restore $1.2 billion of value to Pro Medicus, and bulls think the stock – which is already trading at a sky-high multiple – has further to run.
Pro Medicus reports 1H results
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
The Aussies hoping to make a fortune from Apple’s Vision Pro
The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.
Pro Medicus founders in $176m selldown; Unified Capital nabs trade
Fund managers sources said Anthony Hall and Sam Hupert had stockbroker Unified Capital Partners seeking buyers for 2 million shares at $88 apiece.